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Summary
 
T cells specific for nucleosomal autoepitopes are selectively expanded in lupus mice and these
Th cells drive autoimmune B cells to produce pathogenic antinuclear antibodies. We trans-
fected the TCR-
 
a
 
 and -
 
b
 
 chain genes of a representative, pathogenic autoantibody-inducing
Th clone specific for the nucleosomal core histone peptide H4
 
71–94
 
 into TCR-negative recipi-
ent cells. Although the autoimmune TCRs were originally derived from SNF1 (I-A
 
d/q
 
) mice,
the transfectants could recognize the nucleosomal autoepitope presented by APC-bearing I-A
molecules of all haplotypes tested, as well as human DR molecules. Competition assays indi-
cated that the autoepitopes bound to the MHC class II groove. Most remarkably, MHC-unre-
stricted recognition of the nucleosomal peptide epitope was conferred by the lupus TCR-
 
a
 
chain even when it paired with a TCR-
 
b
 
 chain of irrelevant specificity. Several other disease-
relevant Th clones and splenic T cells of lupus mice had similar properties. The TCR-
 
a
 
 chains
of these murine lupus Th clones shared related motifs and charged residues in their CDRs, and
similar motifs were apparent even in TCR-
 
a
 
 chains of human lupus Th clones. The lupus
TCR-
 
a
 
 chains probably contact the nucleosomal peptide complexed with MHC with rela-
tively high affinity/avidity to sustain TCR signaling, because CD4 coreceptor was not required
for promiscuous recognition. Indeed, pathogenic autoantibody-inducing, CD4-negative,
TCR-
 
ab
 
1
 
 Th cells are expanded in systemic lupus erythematosus. These results have implica-
tions regarding thymic selection and peripheral expansion of nucleosome-specific T cells in lu-
pus. They also suggest that universally tolerogenic epitopes could be designed for therapy of lu-
pus patients with diverse HLA alleles. We propose to designate nucleosomes and other antigens
bearing universal epitopes “Pantigens” (for promiscuous antigens).
 
I
 
n murine, as well as human systemic lupus erythematosus
(SLE), the production of nephritogenic antinuclear au-
toantibodies by autoimmune B cells is driven by cognate
interactions with specific autoimmune Th cells (1–7). The
pathogenic autoantibody-inducing Th cells of lupus have
been cloned from (SWR 
 
3
 
 NZB)F1 (SNF1)
 
1
 
 mice and also
from patients with lupus nephritis. Representative Th clones
from the SNF1 mice can precipitate glomerulonephritis upon
transfer into preautoimmune animals, which establishes their
relevance to disease (2). In SNF1 mice, the majority of
these pathogenic Th clones are specific for nucleosomal
peptides, which are processed and presented by the classical
MHC II pathway (3, 6). Nucleosomes are routinely re-
leased from apoptotic cells and this event is not unique to
lupus (8–10). However, the spontaneous expansion of nu-
cleosome-specific T cells is a lupus-specific event that oc-
curs very early in life (3, 6). These Th cells are essential for
sustaining the pathogenic autoantibody-producing B cells
of lupus (4). Without such T cell help, the potentially
pathogenic B cells that arise even in normal subjects as an
accompaniment of the immune response to common path-
ogens are destined to undergo apoptosis (11, 12). The pres-
ence of anionic residues in the junctional regions (CDR3)
of the TCRs of these lupus Th cells suggested that they
could be specific for peptides with cationic residues (2, 13,
14). Indeed, the Th clones of lupus were found to be spe-
cific for nucleosomal peptides containing multiple charged
residues (3, 6).
 
1
 
Abbreviations used in this paper:
 
 HEL, hen egg lysozyme; SNF1, (SWR 
 
3
 
NZB)F1.
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Promiscuous Autoantigens and TCRs of Lupus
 
To further investigate the structural basis for this autoim-
mune recognition event, we have cloned and expressed the
TCR-
 
a
 
 and -
 
b
 
 chain genes of the prototypic pathogenic
autoantibody-inducing Th clone, 3A, which accelerates lu-
pus nephritis in SNF1 mice. The TCR of this representa-
tive pathogenic Th clone is specific for a peptide spanning
residues 71–94 of the nucleosomal core histone H4. H4
 
71–94
 
is in contact with DNA in the native nucleosome particle,
thus allowing this epitope to be protected during autoanti-
gen processing (6). In this study, we report that recognition
of nucleosomal autoepitopes is MHC-dependent, but un-
restricted. Remarkably, the TCR-
 
a
 
 chain of the patho-
genic Th clone is critical for this promiscuous recognition
and nucleosomal peptide specificity, and this recognition
response is CD4 coreceptor–independent.
 
Materials and Methods
 
Mice.
 
BALB/c (H-2
 
d
 
), NZB (H-2
 
d
 
), NZW (H-2
 
z
 
), SWR
(H-2
 
q
 
), C3H (H-2
 
k
 
), (BALB/c 
 
3
 
 SWR)F1 (H-2
 
d/q
 
), B6.C (H-
2
 
bm12
 
), B10.M (H-2
 
f
 
), B10.S (H-2
 
s
 
), B10RIII (H-2
 
r
 
), and B10.PL
(H-2
 
u
 
) mice were from The Jackson Laboratory (Bar Harbor,
ME). SNF1 mice (H-2
 
d/q
 
) were bred at Northwestern University
animal facility.
 
Antibodies.
 
Hybridomas producing mAbs against Thy-1.2
(TIB99), CD3 (145-2C11), CD4 (GK1.5), I-A
 
b/d/q
 
 (TIB120),
and I-A
 
d
 
 (HB3/MKD6) were acquired from the American Type
Culture Collection (ATCC, Rockville, MD). Anti–I-A
 
q
 
 (MKQ7)
was from Phillipa Marrack (National Jewish Center for Immunol-
ogy, Denver, CO). Anti–I-E
 
d
 
 (14-4-4S) was from Laurie Glim-
cher (Harvard University, MA) (3). Anti–HLA-DR (L243), anti-
DP (B7/21), and anti-DQ (Sk10) were from Becton Dickinson
(San Jose, CA). All antibodies were 10-times-concentrated by
standard method of ammonium sulphate precipitation. Anti–IL-2,
biotinylated anti–IL-2, biotinylated anti-V
 
b
 
4, biotinylated anti-
V
 
b
 
8, FITC-conjugated anti-TCR-
 
a
 
/
 
b
 
, and purified anti-CD4
mAbs (RM4.5) were purchased from PharMingen (San Diego, CA).
 
Antigens.
 
Nucleosomes were prepared as previously de-
scribed (3). Overlapping core histone peptides from nucleosomes
corresponding to the regions found to bear pathogenic Th cell
epitopes were synthesized by FMOC chemistry (Chiron Tech-
nologies, San Diego, CA; reference 6).
 
Cells.
 
The cloning of pathogenic autoantibody-inducing Th
cells from SNF1 mice with lupus nephritis has been previously
described (1, 2). Th clones were rested for 10 d before the assays.
Fresh splenic CD4
 
1
 
 T cells were isolated from 4–5 mo-old SNF1
female mice by nylon wool column followed by the lysis of
CD8
 
1
 
 cells and contaminating B cells with mAb and C
 
9
 
 (3, 6).
Short-term T cell lines (polyclonal) were prepared by culturing
the splenic CD4
 
1
 
 T cells with nucleosome-pulsed APCs plus rIL-2
(25 U/ml) for 5 d and then being rested for 7–10 d before the as-
says. The 4G4 clone (TCR-negative T cell hybridoma) was pro-
vided by Charles A. Janeway, Jr. (Yale University, New Haven,
CT; reference 15). The EL-4 T cell lymphoma clone, EL-4.IL-2
(TIB39), was from ATCC. Splenic APCs were isolated from 4-wk
old mice of different MHC backgrounds by depleting erythro-
cytes in Red Cell Lysis Buffer (Sigma Chemical Co., St. Louis,
MO), followed by anti-Thy1.2 (TIB99) and rabbit complement
treatment (3, 6). After irradiating (3,000 rad), the cells were
pulsed with antigens by plating into 96-well plates (5 
 
3
 
 10
 
5
 
 cells/
well) in 100 
 
m
 
l of serum-free HL-1 medium (Ventrex Laborato-
ries, Portland, ME) at 37
 
8
 
C for 4–16 h, and then were washed for
presentation. Two clones of EBV transformed B cell line from
human subjects previously described (7) were also used as APCs.
 
Gene Constructs.
 
The TCR-
 
a
 
 and -
 
b
 
 shuttle vectors with or
without the hen egg lysozyme (HEL)-specific 3A9
 
a
 
 and 3A9
 
b
 
TCR constructs were provided by Mark M. Davis (Stanford
University, CA; references 16, 17). The CD4 construct was ob-
tained from Charles A. Janeway, Jr. (15). The functionally rear-
ranged AV13S3J41 and BV4S1J2S6 region genes of the 
 
a
 
 and 
 
b
 
chain of the TCR of nucleosome-specific lupus Th clone 3A
were amplified by PCR from genomic DNA of 3A with oligo-
nucleotide primers containing splice acceptor and donor sites. For
the TCR-
 
a
 
 gene, the forward primer, V
 
a
 
13-5
 
9
 
-XhoI (AAA
CTC GAG GGA AAG GGA TGA CAT CAC AGC), and the
reverse primer, J
 
a
 
41-3
 
9
 
-NotI (AAA ATT GCG GCC GCG
ATA GCT CCT TCT GCA GGT TCA G), were designed to
introduce a XhoI cloning site 57 bp 5
 
9
 
 of the ATG and a NotI
site 74 bp 3
 
9
 
 of the splice donor sequence, respectively. This am-
plified fragment was inserted into the TCR-
 
a
 
 shuttle vector at
the XhoI and NotI sites. The TCR-
 
a
 
 shuttle vector contains the
 
Ecogpt
 
 gene which was used for selection. For the TCR-
 
b
 
 gene,
the forward primer, V
 
b
 
4-5
 
9
 
-ClaI (CGC TTG TAT CGA TTT
CTA CAA TTA TCT TGA GGA T), and the reverse primer,
J
 
b
 
2-3
 
9
 
-NotI (AAA ATT GCG GCC GCC GAG AGA TGT
GAA TCT TAC CTA AA), were designed to introduce a ClaI
cloning site 44 bp 5
 
9
 
 of the splice acceptor site and a NotI site 17
bp 3
 
9
 
 of the splice donor site, respectively. The genomic PCR-
amplified fragment was then inserted into the 
 
b
 
 shuttle vector at
the ClaI and NotI sites. Both constructs were sequenced to en-
sure fidelity during amplification, then excised by cleavage at the
SalI site in the plasmid vector. The CD4 construct was linearized
by cleavage at the ScaI site.
 
Transfection.
 
TCR-negative 4G4 cells were transfected with
DNA constructs in four combinations: 3A
 
a
 
/3A
 
b
 
; 3A
 
a
 
/3A9
 
b
 
;
3A9
 
a
 
/3A
 
b
 
; and 3A9
 
a
 
/3A9
 
b
 
 (10 
 
m
 
g/construct), along with a
CD4 construct (5 
 
m
 
g) by electroporation using a GenePulser as
suggested by the manufacturer (Bio-Rad, Hercules, CA). EL-4
cells were transfected with DNA constructs in six combinations:
3A
 
a
 
; 3A
 
b
 
; 3A
 
a
 
/3A
 
b
 
; 3A9
 
a
 
; 3A9
 
b
 
; and 3A9
 
a
 
/3A9
 
b
 
 (2.5–5 
 
m
 
g/
construct) by cationic lipid–mediated DNA transfection using Li-
pofectin Reagent following the manufacter’s protocol (GIBCO
BRL, Gaithersburg, MD). After 48 h, HMX selection was started
(Hypoxathine, 15 
 
m
 
g/ml; Mycophenolic Acid, 3 
 
m
 
g/ml; Xathine,
200 
 
m
 
g/ml). Resistant cells were then subcloned and screened for
V
 
b
 
4 (for 3A) and V
 
b
 
8 (for 3A9) expression by flow cytometry,
and Va13 (for 3A) and Va3 (for 3A9) by reverse transcription
PCR. Positive clones were tested for antigen specificity.
Reverse Transcription PCR Analysis. Total RNA was pre-
pared from each transfectant using TRIzol Reagent (GIBCO
BRL), converted to cDNA by reverse transcription using the Gene-
Amp RNA PCR Kit (Perkin-Elmer, Norwalk, CT), and ampli-
fied for 35 cycles (958C for 45 s, 608C for 45 s/cycle) with Taq
polymerase. For 3A TCR-a detection, the forward primer
3ACDR3SEN (AGT GGG AAC ACG GGT TAC CA), located
in the CDR3-Ja41 region of clone 3A TCR-a chain, and re-
verse primer Ca-EX1 (GAC CCA AAG CAG CTT TTG GA),
located in the Ca exon 1, were used. For clone 3A9 TCR-a de-
tection, the forward primer Va3 (AAGTACTATTCCGGAG-
ACCC) and reverse primer CaA (TGGCGTTGGTCTCTTTG
AAG) were used (18).
Flow Cytometric Analysis. 106 cells were incubated on ice for
30 min with 20 ml of FITC-conjugated anti–TCR-a/b (1:40),
FITC-conjugated anti-CD4 (1:40), biotinylated anti-Vb4 (1:40),369 Shi et al.
or biotinylated anti-Vb8 (1:40) followed by staining with PE-
conjugated streptavidin (GIBCO BRL) at 10 mg/ml. Stained cells
were analyzed using a Becton Dickinson FACScanÒ flow cytom-
eter. In all cases, dead cells were gated out using propidium io-
dide.
T Cell Stimulation and Inhibition Assay. Transfectants (105), Th
clones (105), fresh splenic CD41 T cells (5 3 105), or short-term
T cell lines (5 3 105) were cultured either with irradiated APCs
(5 3 105) that had been prepulsed with various concentrations of
antigens and washed, or with APC and anti-CD3 mAb. The cul-
tures were done in triplicate in flat-bottomed 96-well plates with
or without ionomycin (10–100 ng/ml). For antibody blocking,
anti-CD4 mAb (purified RM4.5 or GK1.5) or mAb to MHC
class II antigens were added to the cultures. After 24–36 h of in-
cubation, IL-2 secretion was measured by harvesting 100 ml of
culture supernatant from each well, which was added into a 96-
well Nunc-Immuno Plate (MaxiSorbTM, Dynatech Laboratories,
Chantilly, VA) that had been coated with anti–IL-2 (1 mg/ml),
and blocked with 10% horse serum in PBS. After incubation at
48C overnight, the plate was washed and revealed with biotiny-
lated anti–IL-2 (1 mg/ml) and horseradish peroxidase–conjugated
streptavidin (1:2000) (Sigma Chemical Co.), followed by the sub-
strate TMB (Sigma Chemical Co.) at room temperature for z30
min, then stopped by using 1 N H2SO4 and read immediately at
450 nM. Standard curves for each assay were obtained with
known quantities of mouse rIL-2.
Competitive Assay for MHC ClassII Binding. Quantitative as-
says to determine the binding affinity of nucleosomal histone
peptides to purified MHC class II molecules on the basis of com-
petitive inhibition of binding of a known peptide ligand were
performed as previously described (19, 20).
Results
Structural and Functional Properties of the Pathogenic Th
Clones of Lupus. Approximately 15% of 268 T cell clones
derived from T cells that are spontaneously activated in ne-
phritic SNF1 mice have the ability to selectively augment
the production of IgG anti-DNA and anti-nucleosome au-
toantibodies when cocultured with autologous B cells (1–3,
13). Similar Th cells are also found in patients with lupus
nephritis (5, 7). Moreover, representative SNF1-derived
clones (H/L-3A and L-1A) rapidly precipitate lupus ne-
phritis upon transfer into young preautoimmune mice (2,
4). A compilation of such pathogenic Th clones is shown
in Figure 1. The TCR gene usage of the clones previously
published (2, 13) has been revised according to the most
recent nomenclature (21). Each of the lupus Th clones ex-
presses a single functional TCR-a and -b (2, 13). The nu-
cleosome specificity of several additional hybridoma clones
included in this panel was unmasked by using a suboptimal
dose (50 ng/ml) of ionomycin that does not induce stimu-
lation in the absence of antigen (Fig. 1). It is likely that the
requirement for a suboptimal dose of ionomycin reflects a
partially impaired antigen-specific signaling pathway in some
of the Th hybridomas.
The TCR-a Chain of a Pathogenic Th Clone Confers Nu-
cleosome Specificity. The functionally rearranged TCR-a
and -b chain genes from the prototypic lupus Th clone 3A
(H/L-3A) were inserted into TCR-a and -b shuttle vec-
tors and transfected in different combinations into the
TCR loss mutant 4G4, as well as the EL4 T-cell lym-
phoma lines. 3A is nucleosome specific, and its epitope has
been mapped to the core histone H471–94 region. This pep-
tide epitope can precipitate severe lupus nephritis in vivo
by inducing similar Th cells, and T cells spontaneously
primed to this epitope are prevalent in the spleens of very
young SNF1 lupus-prone mice (6). Control transfections
of different TCR-a and -b chain combinations were per-
formed with HEL-specific 3A9 TCR-a and -b constructs
(16, 17, 22). Figure 2 (A–C) shows stable transfectants ex-
pressing the respective TCRs. The 4G4 line was found to
have surface TCR expression (as detected by anti-CD3 or
anti–TCR-a/b mAb staining) when both a and b TCR
constructs were used for transfections but not with either of
them alone. The EL4 transfectants express the transfected
TCR along with the EL4’s own endogenous TCR, the
specificity of which is not known. The sequence of the
EL4 TCR-a is unknown, but we identified its TCR Vb as
Vb 12 (BV12S1), and furthermore sequenced its junctional
region (see below).
Figure 3 shows that the transfectants bearing the TCR of
Th clone 3A have the same antigenic specificity and MHC-
dependence as the donor pathogenic Th clone from SNF1
lupus-prone mice. The nucleosomal epitope is presented
by I-Ad or I-Aq molecules of the SNF1 (H-2d/q) APCs but
not I-Ed. Moreover, the response of the transfected cells to
the nucleosomal epitope was as robust as that to anti-CD3
antibody stimulation. Surprisingly, the TCR-a chain of Th
clone 3A in combination with either the TCR-b of HEL-
Figure 1. Summary of pathogenic anti-DNA autoantibody-inducing
Th clones derived from SNF1 mice with lupus nephritis (1–3, 13). L,
cloned Th lines; H, Th hybridomas derived directly from splenic T cells;
H/L, hybridomas derived from cloned Th lines by fusion with TCR-neg-
ative BW5147 thymoma, after initial functional characterization. These H/L
hybridomas retained their nucleosome specificity and pathogenic autoan-
tibody-inducing ability. A proportion of the Th clones that were previ-
ously found to be unresponsive to nucleosomes (3) were retested in this
study in the presence of suboptimal doses of ionomycin that unmasked
the nucleosome specificity of some Th clones (H-15E3 and H-16G10).
*, help for IgG autoantibody production is expressed as fold increase in
antibody production when Th clones were cocultured with syngeneic B
cells as compared with control cultures containing B cells alone. **, the
TCR-a and -b chain genes expressed by the Th clones were renamed ac-
cording to WHO-IUIS nomenclature (21). Optimal results from .10 ex-
periments are shown.370 Promiscuous Autoantigens and TCRs of Lupus
specific clone 3A9 or the EL4 TCR-b chain (unknown
specificity) was sufficient to confer the MHC-dependent
nucleosome specificity (Fig. 3). In contrast, the TCR-b
chain of the Th clone 3A in combination with the TCR-a
of EL4 or the HEL-specific clone 3A9 could not reconsti-
tute nucleosome recognition (Fig. 3). Moreover, unlike the
nucleosome-specific TCR-a of lupus clone 3A, the TCR-
a chain of 3A9 required pairing with 3A9 TCR-b to re-
constitute HEL specificity that was restricted to I-Ak (refer-
ence 16 and data not shown).
Nucleosome Presentation and Recognition by Lupus T Cells
are Promiscuous. Another surprising finding was that the
nucleosomal epitopes could be presented to the transfec-
tants bearing colne 3A TCR by almost all MHC II haplo-
type APCs tested, including human DR molecules (Fig. 4).
Again, the promiscuous recognition was dependent upon the
TCR-a chain of the pathogenic lupus Th clone (Fig. 4, A
and C), and pairing with its TCR-b chain did not restrict
its promiscuity (Fig. 4, B and D). Moreover, the nucleo-
some-specific TCR did not mount an alloreactive response
against the different APCs. The promiscuous recognition
of nucleosomal antigen was also a property of three other
lupus Th clones (H-16G10, H-15E3, and H-16B6) in this
SNF1-derived panel (Fig. 1), that shared specificity for the
H471–94 peptide; however, two Th clones (H/L-9w7 and
H-12C4) in the group were restricted to syngeneic MHC
(Fig. 5 and data not shown). Interestingly, the promiscuous
Th clone H-16G10 expresses the same TCR Va family as
clone 3A, but the others use members from various other
TCR families (Fig. 1).
The universal presentation and promiscuous recognition
of nucleosome epitopes were not just limited to the trans-
fectants or the pathogenic Th clones. Freshly obtained CD41
T cells or short-term T cell lines from SNF1 lupus mice also
Figure 2. (A) 3A TCR-a and -b chain gene constructs. Functionally
rearranged segments of TCR genes AV13S3J41 and BV4S1DJ2S6, ex-
pressed by the prototypic pathogenic autoantibody-inducing Th clone 3A
(H/L-3A), were amplified from genomic DNA and inserted into the
TCR expression shuttle vectors (17). (B, top) Stable transfection of the
3Aa chain gene in 4G4 cells. Transcription of TCR-a chain gene is
shown. Total RNA was prepared from each transfectant, converted to
cDNA by reverse transcription, amplified by Taq polymerase using
3ACDR3SEN forward and Ca-EX1 reverse primers, then separated on a
1% agarose. Lane 1, H/L-3A (positive control, the TCR donor lupus Th
clone 3A); lane 2, 4G4 (TCR-negative recipient); lanes 3 and 5, examples
of two separate clones of 4G4 transfected with 3Aa/3Ab genes; lanes 4
and 6, two clones of 3Aa/3A9b-transfected 4G4. Integration of 3Aa
construct into genomic DNA of respective transfectants was detected by
using the primers Va13-59-XhoI and Ja41-39-NotI to amplify the spe-
cific AV13S3J41 fragment by PCR (data not shown). (Bottom) Stable
transfection of 3Aa chain gene in EL-4 cells. Transcription of TCR-a
chain gene was detected by reverse transcription PCR as above. The
method was specific because EL-4’s own endogenous TCR-a was not
amplified. Lane 1, H/L-3A; lane 2, EL-4 (recipient); lanes 3–5, three sep-
arate clones of 3Aa gene-transfected EL-4; lanes 6 and 7: two examples
of clones with 3Aa/3Ab genes in EL-4; lanes 8 and 9, two clones of 3Ab
gene-transfected EL-4. Integration of 3Aa construct into genomic DNA
of the transfectants was detected as above (data not shown). Stable trans-
fection of the HEL-specific T cell–derived 3A9a chain gene was detected
by reverse transcription PCR using primers Va3 and CaA (data not
shown). (C) Expression of transfected 3Ab chain (Vb4) and 3A9b chain
(Vb8) in 4G4 and EL-4 cells, analyzed by flow cytometry after staining
with anti-Vb4-biotin or anti-Vb8-biotin followed by PE-conjugated
streptavidin. Lane 1, 3Aa/3Ab in 4G4; lane 2, 4G4; lane 3, 3Ab in EL-4;
lane 4, EL-4; lane 5, 3Aa/3A9b in 4G4; lane 6, 4G4. PCR of genomic
DNA showed stable integration of the transfected TCR-b genes (data not
shown). The mean fluorescence intensities of Vb4 or Vb8 staining of the
transfectants were similar to the donor Th clone 3A or 3A9, respectively
(data not shown).371 Shi et al.
had this property (Fig. 6). In lupus-prone mice, unlike nor-
mal strains, T cells are spontaneously primed in vivo against
nucleosomal epitopes (3, 6). Therefore, the response of
such nucleosome-primed T cells could be detected early,
such as in a 24 h, IL-2 production assay, before alloreactive
T cells could obscure the autoantigen-specific signal by
mounting a primary mixed lymphocyte reaction. Promiscu-
ous recognition of the nucleosomal H471–94 peptide became
detectable after just one round of nucleosome stimulation
of the splenic CD41 T cell, which probably increased the
frequency of such Th cells in the bulk population (Fig. 6, A
versus B).
Nucleosomal Peptide Epitopes Bind to Diverse MHC II Mole-
cules. In competition assays with known conventional
peptide antigens that bind to the class II groove, H471–94
and a series of truncated peptides spanning this region
bound several murine I-A molecules and also human DR1
(Fig. 7). Markedly higher affinity for all the class II alleles
tested was noted for the peptide spanning residues 76–90 of
H4, located nearer to the COOH terminus of the parent
Figure 3. IL-2 production by 4G4 (A) and EL-4 (B) transfectants in response to the nucleosome presented by SNF1 APCs. Concentrations between
0.1 and 1 mg/ml were selected for subsequent assays except where indicated. MHC class II is required for nucleosomal antigen presentation to the EL-4
(C) and 4G4 (D) transfectants. Transfectants were cultured with irradiated SNF1 (H-2d/q) APCs that had been prepulsed with nucleosomes (Nuc, 1 mg/
ml) or the H4 (71–94) peptide (1 mM) in the presence of anti–I-Ad, anti–I-Aq, anti–I-Ab/d/q, anti–I-Ed, or control Ig. Culture supernatants were collected
and tested for the presence of IL-2 by ELISA. Data are representative of more than five experiments and the data shown are means of assays done in trip-
licate. SD ,10%.372 Promiscuous Autoantigens and TCRs of Lupus
Figure 4. Promiscuous recognition of nucleosomal antigen presented by APCs of various MHC haplotypes by 4G4 transfected with 3Aa/3A9b (A) or
3Aa/3Ab (B) TCRs. In Figs. 4–6, the concentration of nucleosomes used to prepulse the APCs was 1 mg/ml and that of H4 peptide was 1 mM. The
APC haplotypes are indicated, H-2d/q here designates (BALB/c 3 SWR)F1 APCs. Nucleosomal antigen presented by xenogeneic (human) MHC class
II molecules is also recognized by 4G4 transfected with 3Aa/3A9b (C) or 3Aa/3Ab (D) TCRs. Transfectants were cultured with irradiated human
HLA-DR2,4, w53 or DR1,3, w52 haplotype bearing EBV-B cell lines that had been prepulsed with antigen in the presence of anti–HLA-DR or control
antibody (anti-DP, anti-DQ). Data are representative of more than five experiments. Mean IL-2 production of triplicate assays are shown; SD ,10%.
Figure 5. Promiscuous recognition of nucleosomal antigen by other lupus Th clones from SNF1 mice: clones H-16G10 (A), H-15E3, and H-16B6
(data not shown) are promiscuous. However, recognition by Th clones H/L-9W7 (B) and H-12C4 (data not shown) are restricted to syngeneic MHC
(H-2d/q indicates SNF1 APCs). Data from representative experiments are presented as in previous figures.373 Shi et al.
peptide H471–94. The TCRs of 3A and other lupus Th clones
in the panel (Fig. 1), are mainly specific for H471–94. How-
ever, despite having a single pair of functional TCR-a/b,
each of them also recognized H416–39, thus revealing a de-
generate or cross-reactive specificity (6, 13) analogous to
other TCR–antigen systems (23, 24). H416–39 and its trun-
cations also bound to the different class II alleles, particu-
larly the peptides spanning position 22–39 in this region.
Thus, this region of nucleosomal core histone may also be
promiscuously recognized. However, another epitope for
other pathogenic Th cells of lupus, which was previously
localized in histone H2B10–33 (6), did not show promiscu-
ous binding (data not shown), suggesting that such a bind-
ing pattern is not found in every lupus-associated autoepi-
topes.
Although the truncated H476–90 bound to MHC with
the highest affinity, it did not stimulate the 3A clone TCR
as strongly as did the parental H471–94 peptide (data not
shown). And, unlike the case of the H471–94 epitope (Fig. 6
B), reactivity to H476–90 could not be detected in freshly
obtained CD41 T cells or short-term T cell lines from
SNF1 mice (data not shown).
Shared Motif in the Nucleosome-specific TCR-a Chains.
A comparison of the sequences of the various TCRs ana-
lyzed here revealed that the sequence motif of IRSNMERE
(or conservative variations of it) was frequently present in
the CDR2 region (position 50–57) of the nucleosome-spe-
cific TCR Va chains (Fig. 8 A). Furthermore, charged res-
idues in the flanking region (position 57–62) of the CDR2
were also prevalent. These features were not found in the
HEL-specific TCR-a chain.
It should be noted that TCR-a of H-10B5, another
pathogenic autoantibody-inducing Th clone in the panel
that did not respond to nucleosomal antigens, shared simi-
lar motifs with the nucleosome-specific TCR-a. The anti-
gen specificity of this lupus clone is not known but it may
possibly be specific for other chromosomal proteins with
charged residues similar to the nucleosomal histones (7).
Interestingly, the TCR Vb chains of EL-4 or HEL-spe-
cific 3A9 that could pair with 3A TCR-a for its promiscu-
ous recognition of nucleosomal H4 epitope contained sev-
eral negatively charged residues in their CDR3, just like
the TCR Vb chains of other nucleosome-specific Th
clones (Fig. 8 B).
CD4 Coreceptor Is Not Required for Promiscuous Recognition
of Nucleosomes. The anti-CD4 mAbs, GK1.5 and RM4.5,
which are known to inhibit antigen-specific responses (25),
could not block the recognition of nucleosomal antigens by
4G4 and EL-4 transfectants expressing 3A TCR-a chain
(Fig. 9 and data not shown). Moreover, the promiscuous
recognition of nucleosome antigens by these transfectants
(Figs. 3 and 4) could not be blocked by the anti-CD4 mAb
even at saturating concentrations (data not shown). The
transfectants were surface CD41 by flow cytometry (data
not shown). In addition, 4G4 transfectants that expressed
Figure 6. Promiscuous recognition of nucleosomes by splenic CD41 T cells of SNF1 mice. Freshly isolated splenic CD41 T cells (A) or shortterm
CD41 T cell line from SNF1 mice (B) were cultured with irradiated APCs of various MHC haplotypes that had been prepulsed with antigen. Culture su-
pernatants were assayed after 24 h for IL-2. For making short-term lines, splenic CD41 T cells were stimulated once with nucleosome ex vivo in the
presence of IL-2 and then rested for 10 d. Mean of triplicate assays are shown (SD ,10%). Data are representative of three experiments.
Figure 7. Binding of histone H4-derived truncated peptides to mouse
and human MHC class II molecules in competition asssays. The data is
presented as 50% inhibitory concentration in nanomoles (nM). Peptide
binding was ranked as follows: good binders (binding affinity ,100 nM);
intermediate binders (binding affinity 5 100–1,000 nM); low binders
(binding affinity 5 1,000–10,000 nM); and negative binders (binding af-
finity .10,000 nM).374 Promiscuous Autoantigens and TCRs of Lupus
the 3A TCR-a chain (with 3A9 TCR-b), but had lost sur-
face expression of CD4, also responded to nucleosomes and
H471–94 peptide in a promiscuous but MHC class II–depen-
dent manner, and their responses were equivalent to those
shown in Figures 3 and 4 (data not shown). Furthermore,
we tested the pathogenic autoantibody-inducing CD41 Th
clones, H/L- 3A, H-15E3, and H-16G10, and found that
they were also relatively resistant to anti-CD4 blocking in
their ability to promiscuously recognize the nucleosomal
H471–94 peptide (Fig. 9 and data not shown). Moreover, the
addition of anti-CD4 mAb did not result in a significant
shift in the concentrations of peptide required to stimulate
the Th clones in most cases. Finally, independently derived,
short-term CD41 T cell lines freshly obtained from differ-
ent SNF1 animals also contained a substantial population of
T cells that were CD4-independent in recognition of the
nucleosomal epitope. Anti-CD4 blocking could only par-
tially inhibit (from 50 to 70%) promiscuous recognition of
nucleosomal H471–94 peptide by the CD41 T cell lines at all
the different concentrations of antigen tested (Fig. 9).
Discussion
These studies show that certain nucleosomal peptides
recognized by spontaneously arising, autoimmune Th cells
that cause lupus nephritis are degenrate MHC binders, and
the corresponding Th cells that recognize these peptides are
MHC unrestricted although they were educated in the I-Ad/q
thymus of SNF1 mice. The presentation of the nucleoso-
mal H4 peptides (71–94 region) was clearly MHC depen-
dent as shown by anti–class II antibody blocking. Either
mAb to I-Ad or I-Aq could almost completely block nu-
cleosome presentation by SNF1 (I-Ad/q) APCs, because the
antibodies have cross-reactive specificity due to the highly
homologous structure of I-Ad and I-Aq molecules (Fig. 3,
reference 26, and data not shown). Presentation by class I
(classical or nonclassical) is ruled out because transfectants
derived from the mouse T cell lymphoma EL-4, which
lacks class II but is capable of presenting antigen with class I
molecules (27), did not produce IL-2 by themselves when
exposed to the nucleosomal peptide (Fig. 3). Moreover,
the nucleosomal peptides most likely bound the diverse set
of class II molecules tested through engagement of the clas-
sical binding groove of MHC, because they efficiently
competed with well-characterized peptides known to bind
to the grooves. Furthermore, previous work has established
that nucleosomes and their peptide epitopes do not behave
as superantigens (3, 6, 13). Truncation of the H471–94 pep-
tide increased its affinity for the class II alleles, and indeed
its core region (amino acid position 78–89) does have a se-
quence motif (RKTVTAMDVVYA) that is homologous
to other universal epitopes (20). However, truncation of
Figure 8. Amino acid se-
quences of CDRs of TCR-a (A)
and -b ( B ), chains relevant to
this study, compiled from refer-
ences 2, 7, and 13, and aligned
(21). All sequences are from
mouse T cells except for DD2,
which is a human lupus Th clone
(7). Updated TCR-a chain se-
quence of HEL-specific clone
3A9 (52) was provided by Paul
Allen (Washington University,
St. Louis, MO). The EL-4
TCR-b chain (B) was sequenced
in this study (available from
EMBL/GenBank/DDBJ under
accession number BankIt 13531
AF020206).375 Shi et al.
the 24-mer H4 peptide to 15-mer decreased T cell recog-
nition, suggesting that residues outside the MHC-binding
core region can either directly or indirectly affect TCR en-
gagement of MHC–peptide complexes (28, 29). Another
degenerate MHC-binding and promiscuous T cell recogni-
tion epitope was mapped to residues 16–39 of nucleosomal
histone H4. However, another T cell epitope in histone
H2B (6) did not share those properties. These results sug-
gest that nucleosomal autoantigens are frequently but not
always associated with degenerate MHC binding and pro-
miscuous recognition by lupus T cells.
Our results demonstrate that promiscuous recognition of
nucleosomal epitopes by single a/b pairs of autoimmune
TCRs is a property conferred by the TCR-a chain. In-
deed, lupus susceptibility is not restricted to any particular
MHC haplotype. Different MHC alleles are found in dif-
ferent lupus strains, and the same ones are also present in
normal strains. Interestingly, degenerate MHC binding of
certain myelin basic protein peptides and their recognition
by T cell lines from multiple sclerosis patients have also
been described. However, weakly cross-reactive binding to
only DR molecules was reported, and TCRs responsible
for the degenerate recognition were not analyzed (30).
TCR promiscuity was thought to occur in the context
of DR and its murine homologue, the I-E molecules, as-
suming that the TCRs were recognizing the peptide epi-
topes along with the nonpolymorphic a chain in these
MHC molecules (31, 32). However, this is not the case with
the nucleosomal peptide-specific TCRs described here, or
the universal peptide epitopes described in other systems
(20, 33, 34), where the epitopes either bind or are recog-
nized in the context of both human DR and murine I-A
molecules, the latter being polymorphic in both a and b
chains. In general, promiscuous or cross-reactive recogni-
tion by a TCR is thought to be the basis for positive selec-
tion in the thymus and alloreactivity, i.e., TCRs can some-
how “learn” from one MHC allele to interact with others
(35–37). However, it is notable that although the lupus
TCRs in this study recognized the histone peptide in the
context of the diferent MHC alleles, they were not reactive
to APCs bearing those alleles in the absence of the histone
peptide. Indeed, promiscuous recognition of nucleosomal
epitope was not only a feature of the pathogenic Th clones,
but was also detectable in freshly obtained splenic T cell
populations from the SNF1 mice. In lupus mice, nucleo-
some-primed T cells arise spontaneously and are prevalent
in vivo from an early age (3, 6).
The CDR2 regions of these Th clones appear to have a
related sequence motif and multiple negative residues, which
in combination with other sequences of their TCR-a and
-b chains could confer the property of promiscuous recog-
nition of nucleosomal antigen. TCR-a chain CDR2 has
been implicated in other systems for MHC-antigen recog-
nition (15, 38–41). It is noteworthy that a pathogenic au-
toantibody-inducing Th clone of human lupus that also rec-
ognizes the nucleosomal core histone H4 expresses TCR
Va8 (7), which is homologous to the mouse Va13 gene
family (42) expressed by the murine lupus Th clones 3A
and 16G10. More remarkably, in contrast with an expres-
sion rate of 9% among unselected T cells, the Va8 genes
are expressed by 18 out of 42 (i.e., 43%, but ranging up to
100% in some patients) pathogenic autoantibody-inducing
Th clones from lupus patients, and they also recognize chro-
mosomal proteins (7). Notably, the CDR1 and 2 regions of
this human TCR Va8 gene family share sequence motifs
with the murine Va13 family (42).
Crystallographic data has recently illustrated how recog-
nition of MHC–peptide complexes by monogamous TCR
molecules (43, 44) is largely dependent on a single TCR
Figure 9. Effect of the purified anti-CD4 mAb, RM4.5, on the re-
sponses of lupus T cells to nucleosomal peptide H471–94. Solid symbols
represent anti-CD4 mAb containing cultures and the corresponding cul-
tures without anti-CD4 are designated by open symbols. The MHC hap-
lotypes of different APCs used to present the peptide are shown at the top
of each panel; H-2d/q represents syngeneic SNF1 APCs. Background val-
ues of IL-2 production in corresponding cultures (T cells 1 APC) with-
out antigen have been subtracted from each data point. (Top row) Left
panel shows 4G4 transfected with 3Aa/3a9b TCRs, middle shows Th
clones H/L-3A (circles) and H-15E3 (squares), and right panel shows two
short-term, CD41 T cell lines from SNF1 spleen (squares and circles). Re-
sponses of pathogenic autoantibody-inducing Th clones H/L-3A and
H-15E3 to nucleosomal peptide presented by different allogeneic APC
are shown in second and third rows, respectively, and that of the short-
term T cell lines are shown in the bottom row. The anti-CD4 mAb,
RM4.5, was used at 1 mg/ml, which is the saturating concentration (25),
but similar results were obtained at a concentration of 10 mg/ml. Another
anti-CD4 mAb (GK1.5), concentrated 10 and 5 times from culture super-
natants by ammonium sulphate precipitations, gave similar results (data
not shown). Mean of triplicate assays are shown above. SD ,10%.376 Promiscuous Autoantigens and TCRs of Lupus
pocket engaging a prominent side chain of the peptide an-
tigen. It is thus possible to speculate that nucleosomal pep-
tide antigens that can bind multiple MHC molecules (de-
generate binders) and carry multiple positive charges can
engage certain lupus TCR-a chains that carry multiple bind-
ing pockets and reciprocally charged residues, generating
an interaction of such strength as to overcome the usual ap-
parent requirement for MHC restriction (promiscuous T
cell recognititon). This hypothesis is further supported by
the lack of the requirement of CD4 coreceptor for signal-
ing the promiscuous recognition response by the lupus TCR,
even at the lowest stimulatory concentrations of the au-
toantigen. These results cannot be attributed to possible ex-
pression of TCR at high density in the transfectants, be-
cause other nucleosome-specific lupus Th clones and freshly
prepared CD41 T cell lines from the spleens of SNF1 mice
also shared this property, whereas the HEL-specific TCR
(3A9) transfectants were not promiscuous. Indeed, CD4-
negative, TCR-a/b1 T cells that help in the production of
pathogenic antinuclear autoantibodies are markedly ex-
panded in both human and murine SLE (1, 2, 5, 7). The
beneficial effect of chronic anti-CD4 antibody administra-
tion to lupus mice in vivo (45) is apparently contradictory
to the above observations. However, the therapeutic effect
of anti-CD4 in vivo could be due to a combination of fac-
tors and not exclusively due to an inhibition of CD41 T
cells. The CD4 molecule is also expressed on the surface of
hematopoietic stem cell precursors, which could affect the
generation of autoantigen-presenting APCs and autoim-
mune B cells, not just T cells (46). Significantly, the CD4
molecule is also expressed on APCs such as dendritic cells,
monocytes, and macrophages (47). Thus, anti-CD4 therapy
could interfere with autoantigen presentation and other effec-
tor and inflammatory components of lupus. Moreover, chronic
anti-CD4 antibody therapy generates downregulatory T cells
in vivo (48). Indeed, for anti-CD4 therapy to be effective it
has to be administered repeatedly and for the long term to
lupus-prone mice, beginning early in their lives (45), sug-
gesting that something more than just inhibition of CD41
T helper cells is responsible for the therapeutic effect.
Crystallographic and modeling data also indicate that dif-
ferent TCR–peptide–MHC complexes will have distinct
structural orientations and contact points (14, 23, 41, 43,
44, 49–51). Therefore, analysis of the promiscuous lupus
TCRs in contact with the H4 peptide complexed with dif-
ferent MHC molecules could reveal some unique features
of this trimolecular interaction.
Since the lupus TCR-a chains could confer nucleoso-
mal peptide specificity as well as promiscuity in combina-
tion with TCR-b chains of unrelated specificities, the nu-
cleosome-specific T cell repertoire is potentially vast. How
it is kept in check in normal mice and why they are se-
lected in the lupus thymus are pressing questions that will
be addressed in the transgenic mice we are developing with
these TCR constructs. These studies also open up the pos-
sibility of designing “universally tolerogenic” epitopes for
the therapy of patients with lupus, despite the diversity of
their HLA alleles.
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